These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Contralateral breast cancer: a clinico-pathological study of second primaries in opposite breasts after treatment of breast malignancy. Shankar A, Roy S, Malik A, Kamal VK, Bhandari R, Kishor K, Mahajan M, Sachdev J, Jeyaraj P, Rath G. Asian Pac J Cancer Prev; 2015; 16(3):1207-11. PubMed ID: 25735357 [Abstract] [Full Text] [Related]
25. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses. Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, Lüchtenborg M. Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018 [Abstract] [Full Text] [Related]
26. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Cancer; 2000 Jun 15; 88(12):2739-50. PubMed ID: 10870056 [Abstract] [Full Text] [Related]
29. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results]. Fodor J, Sulyok Z, Polgár C, Major T, Tóth J, Németh G. Magy Seb; 2001 Aug 15; 54(4):209-14. PubMed ID: 11550486 [Abstract] [Full Text] [Related]
36. Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis. Akdeniz D, Schmidt MK, Seynaeve CM, McCool D, Giardiello D, van den Broek AJ, Hauptmann M, Steyerberg EW, Hooning MJ. Breast; 2019 Apr 15; 44():1-14. PubMed ID: 30580169 [Abstract] [Full Text] [Related]
37. Long-term outcome following breast-conserving surgery and radiation therapy. Gage I, Recht A, Gelman R, Nixon AJ, Silver B, Bornstein BA, Harris JR. Int J Radiat Oncol Biol Phys; 1995 Sep 30; 33(2):245-51. PubMed ID: 7673011 [Abstract] [Full Text] [Related]